Development
Microbot Medical Inc.
MBOT
$2.92
$0.051.74%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.60M | 5.19M | 5.60M | 5.77M | 6.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.86M | 11.79M | 13.02M | 13.28M | 14.15M |
| Operating Income | -10.86M | -11.79M | -13.02M | -13.28M | -14.15M |
| Income Before Tax | -10.58M | -11.61M | -12.83M | -13.17M | -14.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.58 | -11.61 | -12.83 | -13.17 | -14.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.58M | -11.61M | -12.83M | -13.17M | -14.03M |
| EBIT | -10.86M | -11.79M | -13.02M | -13.28M | -14.15M |
| EBITDA | -10.75M | -11.68M | -12.92M | -13.18M | -14.05M |
| EPS Basic | -1.20 | -1.48 | -1.73 | -1.82 | -1.97 |
| Normalized Basic EPS | -0.75 | -0.93 | -1.08 | -1.14 | -1.23 |
| EPS Diluted | -1.20 | -1.48 | -1.73 | -1.82 | -1.97 |
| Normalized Diluted EPS | -0.75 | -0.93 | -1.08 | -1.14 | -1.23 |
| Average Basic Shares Outstanding | 36.64M | 32.04M | 29.95M | 29.04M | 28.43M |
| Average Diluted Shares Outstanding | 36.64M | 32.04M | 29.95M | 29.04M | 28.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |